Complement-Dependent Cytotoxicity CDC Crossmatch Test sale cost 2550 AED
Prenatal Diagnostic Screening by Karyotyping Test sale cost 2400 AED Prenatal Diagnostic Screening by Karyotyping Test Cost 3,200 د.إ Original price was: 3,200 د.إ.2,400 د.إCurrent price is: 2,400 د.إ.
CLL Panel DeletionDuplication Detection Test sale cost 2100 AED CLL Panel DeletionDuplication Detection Test Cost 2,800 د.إ Original price was: 2,800 د.إ.2,100 د.إCurrent price is: 2,100 د.إ.
Sale!

Complement-Dependent Cytotoxicity CDC Crossmatch Test Cost

Original price was: 3,000 د.إ.Current price is: 2,550 د.إ.

-15%

The Complement-Dependent Cytotoxicity (CDC) Crossmatch Test is a critical diagnostic procedure used in the field of transplantation immunology to assess the compatibility between a donor’s organ and a potential recipient. This test plays a pivotal role in preventing organ transplant rejection by identifying the presence of pre-existing antibodies in the recipient’s serum that might react against the donor’s antigens. By adding the recipient’s serum to the donor’s lymphocytes in the presence of complement, the test can detect whether the antibodies lead to cell lysis, indicating a positive result and a higher risk of transplant rejection.

Performed at DNA Labs UAE, a leading facility known for its state-of-the-art technology and expertise in genetic and immunological testing, the CDC Crossmatch Test is conducted with the utmost precision and care. The test cost is set at 2550 AED, reflecting the comprehensive approach and advanced techniques employed to ensure accurate and reliable results. This investment is crucial for the success of organ transplants, significantly impacting patient outcomes by guiding the selection of compatible donors and minimizing the risk of transplant rejection.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Complement-Dependent Cytotoxicity CDC Crossmatch Test

At DNA Labs UAE, we offer the Complement-Dependent Cytotoxicity (CDC) Crossmatch Test for organ transplantation. This test helps determine the compatibility between a potential organ donor and recipient by assessing the presence of donor-specific antibodies (DSAs) in the recipient’s blood.

Test Details

The CDC crossmatch test involves mixing the recipient’s serum (containing antibodies) with the donor’s lymphocytes (white blood cells). Complement proteins, which are part of the immune system, are then added to the mixture. If DSAs are present in the recipient’s serum, they will bind to the donor’s lymphocytes, activating the complement system.

This activation leads to the formation of membrane attack complexes that cause cell lysis and death of the donor’s lymphocytes. The degree of cell death is assessed by measuring the release of a marker, such as radioactive isotopes or fluorescent dyes, from the lysed lymphocytes.

Test Name: Complement-Dependent Cytotoxicity CDC Crossmatch Test

Components

  • Price: 2550.0 AED
  • Sample Condition: Blood
  • Report Delivery Method:
  • Test Type:
  • Doctor:
  • Test Department:

Pre Test Information

CDC crossmatching is typically performed before transplantation to identify potential organ rejections. It is especially useful in identifying DSAs that are not detected by other methods, such as flow cytometry crossmatch or solid-phase immunoassays.

Benefits of CDC Crossmatching

CDC crossmatching helps ensure successful organ transplantation and reduces the risk of rejection by identifying incompatible matches. It provides valuable information that may not be detected by other methods, allowing for a more accurate assessment of compatibility between the organ donor and recipient.

By choosing DNA Labs UAE for your CDC crossmatch test, you can have peace of mind knowing that our experienced team will provide accurate and reliable results. We are committed to delivering high-quality services to support organ transplantation and improve patient outcomes.

Test Name Complement-Dependent Cytotoxicity CDC Crossmatch Test
Components
Price 2550.0 AED
Sample Condition Blood
Report Delivery
Method
Test type
Doctor
Test Department:
Pre Test Information
Test Details

Complement-dependent cytotoxicity (CDC) crossmatch is a laboratory test used in organ transplantation to determine the compatibility between a potential organ donor and recipient. It assesses the presence of donor-specific antibodies (DSAs) in the recipient’s blood that can lead to rejection of the transplanted organ.

During a CDC crossmatch, the recipient’s serum (containing antibodies) is mixed with the donor’s lymphocytes (white blood cells). Complement proteins, which are part of the immune system, are then added to the mixture. If DSAs are present in the recipient’s serum, they will bind to the donor’s lymphocytes, activating the complement system. This activation leads to the formation of membrane attack complexes that cause cell lysis and death of the donor’s lymphocytes.

The degree of cell death is assessed by measuring the release of a marker, such as radioactive isotopes or fluorescent dyes, from the lysed lymphocytes. If significant cell death occurs, it indicates that the recipient has DSAs against the donor’s antigens, suggesting an incompatible match.

CDC crossmatching is typically performed before transplantation to identify potential organ rejections. It is especially useful in identifying DSAs that are not detected by other methods, such as flow cytometry crossmatch or solid-phase immunoassays. By identifying incompatible matches, CDC crossmatching helps ensure successful organ transplantation and reduces the risk of rejection.

SKU: TEST-4843 Category:

Related products